Disease-Modifying Therapies in Alzheimer’s Disease: Anti-Amyloid Antibodies and Emerging Therapeutic Approaches

views

Neurology Grand Rounds February 27, 2026 Konstantinos Avgerinos, MD, M.Sc. PGY-4 Neurology Resident Detroit Medical Center, Department of Neurology Wayne State University School of Medicine Department of Neurology Detroit, Michigan

Tags

Disease-Modifying Therapies in Alzheimer’s Disease: Anti-Amyloid Antibodies and Emerging Therapeutic Approaches

Related Media